Provided by Tiger Trade Technology Pte. Ltd.

LIFECORE BIOMEDICAL INC

3.66
-0.2100-5.43%
Post-market: 3.660.00000.00%16:10 EDT
Volume:478.86K
Turnover:1.79M
Market Cap:137.13M
PE:-3.95
High:3.84
Open:3.84
Low:3.64
Close:3.87
52wk High:8.98
52wk Low:3.64
Shares:37.47M
Float Shares:19.02M
Volume Ratio:0.88
T/O Rate:2.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9257
EPS(LYR):-0.5400
ROE:-76.41%
ROA:-3.04%
PB:-9.66
PE(LYR):-6.78

Loading ...

Top News Today/Canada: Goods-Trade Deficit Posted in October

Dow Jones
·
Jan 09

North American Morning Briefing: Stock Futures Rise as 2026 Trading Year Begins

Dow Jones
·
Jan 02

Top News Today/Canada: Organigram Increases Phylos Investment

Dow Jones
·
Jan 01

Lifecore Biomedical Joins Nasdaq Biotech Index

Reuters
·
Dec 18, 2025

Lifecore Biomedical Signs CDMO Agreement with Multinational Pharmaceutical Company

Reuters
·
Dec 17, 2025

Lifecore Biomedical Signs CDMO Master Services Agreement With New Large Multinational Pharmaceutical Customer

THOMSON REUTERS
·
Dec 17, 2025

Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
Dec 16, 2025

Lifecore Biomedical to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Nov 12, 2025

Lifecore Biomedical Q1 EPS $(0.29) Beats $(0.30) Estimate, Sales $31.109M Beat $26.471M Estimate

Benzinga
·
Nov 07, 2025

Press Release: Lifecore Biomedical Reports Financial Results for the Three Months Ended September 30, 2025, and Provides Corporate Update

Dow Jones
·
Nov 07, 2025

Lifecore Biomedical Inc expected to post a loss of 31 cents a share - Earnings Preview

Reuters
·
Nov 05, 2025

Craig-Hallum Sticks to Their Buy Rating for Lifecore Biomedical (LFCR)

TIPRANKS
·
Nov 04, 2025

Lifecore Biomedical Inc. held annual shareholder meeting

Reuters
·
Nov 01, 2025

Craig-Hallum Sticks to Its Buy Rating for Lifecore Biomedical (LFCR)

TIPRANKS
·
Oct 29, 2025

Lifecore Biomedical Inc - Signs Agreement With Leading Global Pharmaceutical Company

THOMSON REUTERS
·
Oct 29, 2025

Lifecore Biomedical: Will Transfer Commercial Manufacturing for Injectable Pharmaceutical Product From Current Manufacturer to Co's Facilities

THOMSON REUTERS
·
Oct 29, 2025

Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company

GlobeNewswire
·
Oct 29, 2025

Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market

GlobeNewswire
·
Oct 28, 2025

Craig-Hallum Sticks to Their Buy Rating for Lifecore Biomedical (LFCR)

TIPRANKS
·
Oct 17, 2025

Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events

GlobeNewswire
·
Oct 13, 2025